InvestorsHub Logo
Followers 126
Posts 5415
Boards Moderated 0
Alias Born 06/09/2020

Re: Sankarad1 post# 485549

Saturday, 06/11/2022 6:53:04 AM

Saturday, June 11, 2022 6:53:04 AM

Post# of 700683
It seems to be the same trial as just talked about here, where GlaxoSmithKline is involved.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169119117

Its a PD1 checkpoint inhibitor like Keytruda. DCVax-L works alone but even better with these inhibitors, as the UCLA Spore 1 project shows and patent for combos with DCVax-L and inhibitors are currently in the making.

DCVax-L is quickly becoming the secret ingredient in the magical sauce.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News